Pfizer Settles Charges Against Its Copayment Card Program

Drug Industry Daily
A A
Pfizer has settled allegations that it falsely marketed its copayment coupon program for its Estring, Quillivant and Flector Patch products.

To View This Article:

Login

Subscribe To Drug Industry Daily